Immune System Diseases
The centre is running studies that target autoimmune conditions such as severe alopecia areata and active axial spondyloarthritis, aiming to evaluate new oral therapies that modulate the immune response.
- Efficacy of upadacitinib in severe alopecia areata
- Assessment of filgotinib for active axial spondyloarthritis
- Long‑term safety monitoring of JAK inhibitor treatment
Centrum Kliniczno-Badawcze J.Brzezicki B.Gornikiewicz-Brzezicka Lekarze sp.p. leverages its expertise to bring innovative treatment options to patients with immune‑mediated diseases.
Musculoskeletal Diseases
Research at the site focuses on joint‑related disorders, including knee osteoarthritis and axial spondyloarthritis, with the goal of improving pain control, function, and disease progression through novel therapeutic approaches.
- Evaluation of new agents for knee osteoarthritis symptom relief
- Investigation of disease‑modifying potential in axial spondyloarthritis
- Integration of metabolic health strategies with musculoskeletal outcomes
The Elbląg facility supports patients by advancing treatments that address the physical challenges of musculoskeletal conditions.
Nutritional and Metabolic Diseases
The institution conducts trials aimed at tackling obesity and overweight, testing innovative compounds designed to promote weight loss and improve metabolic health, often in conjunction with related comorbidities.
- Testing retatrutide for effective weight reduction
- Assessing metabolic impact of emerging anti‑obesity therapies
- Combining weight‑loss interventions with joint health assessments
By participating in these studies, the centre contributes to the development of safer and more effective solutions for metabolic disorders.
